Bartushak Jaime 4/A
4/A · CITIUS ONCOLOGY, INC. · Filed Dec 22, 2025
Insider Transaction Report
Form 4/AAmended
Bartushak Jaime
Chief Financial Officer
Transactions
- Award
Common Stock
2025-09-19+825,000→ 825,000 total
Footnotes (1)
- [F1]Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.